Literature DB >> 14513441

Preoperative risks and outcomes of hip and knee arthroplasty in the Veterans Health Administration.

Frances Weaver1, Denise Hynes, William Hopkinson, Richard Wixson, Shukri Khuri, Jennifer Daley, William G Henderson.   

Abstract

The relationship between patient characteristics and outcomes of total joint arthroplasty (TJA) was examined in a population of veterans treated in VA hospitals. Outcomes included 30-day mortality and morbidity, postoperative length of stay, and readmission caused by surgical complications. A larger proportion of women then men were functionally impaired before surgery in both the hip (22% vs. 14%) and knee samples (14% vs. 7%; all P<.01). Rates of adverse outcomes in this population were very low. Preoperative comorbid conditions, abnormal laboratory values, and being nonwhite were related to poor outcomes of TJA. Gender was a significant independent predictor of morbidity and length of stay for total knee arthroplasty.

Entities:  

Mesh：

Year:  2003        PMID： 14513441     DOI： 10.1016/s0883-5403(03)00259-6

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN： 0883-5403            Impact factor:   4.757


  64 in total

1.  Toward a VA Women's Health Research Agenda: setting evidence-based priorities to improve the health and health care of women veterans.

Authors:  Elizabeth M Yano; Lori A Bastian; Susan M Frayne; Alexandra L Howell; Linda R Lipson; Geraldine McGlynn; Paula P Schnurr; Margaret R Seaver; Ann M Spungen; Stephan D Fihn
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

2.  Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty.

Authors:  J A Singh; J A Sloan
Journal:  Rheumatology (Oxford)       Date:  2008-10-16       Impact factor: 7.580

3.  Race may not affect [correct] outcomes in operatively treated tibia fractures.

Authors:  Jonathan Piposar; John R Fowler; John P Gaughan; Saqib Rehman
Journal:  Clin Orthop Relat Res       Date:  2011-10-21       Impact factor: 4.176

4.  Patterns of care and survival for glioblastoma patients in the Veterans population.

Authors:  Robert T Arrigo; Maxwell Boakye; Stephen L Skirboll
Journal:  J Neurooncol       Date:  2011-09-01       Impact factor: 4.130

Review 5.  Complications for racial and ethnic minority groups after total hip and knee replacement: a review of the literature.

Authors:  Benedict U Nwachukwu; Adrian D Kenny; Elena Losina; Lori B Chibnik; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2010-02       Impact factor: 5.284

6.  Periprosthetic fractures associated with primary total shoulder arthroplasty and primary humeral head replacement: a thirty-three-year study.

Authors:  Jasvinder A Singh; John Sperling; Cathy Schleck; William Harmsen; Robert Cofield
Journal:  J Bone Joint Surg Am       Date:  2012-10-03       Impact factor: 5.284

7.  Prediction Models for 30-Day Mortality and Complications After Total Knee and Hip Arthroplasties for Veteran Health Administration Patients With Osteoarthritis.

Authors:  Alex Hs Harris; Alfred C Kuo; Thomas Bowe; Shalini Gupta; David Nordin; Nicholas J Giori
Journal:  J Arthroplasty       Date:  2017-12-13       Impact factor: 4.757

8.  Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Rheumatology (Oxford)       Date:  2013-01-15       Impact factor: 7.580

9.  Effect of day of the week of primary total hip arthroplasty on length of stay at a university-based teaching medical center.

Authors:  Pranav Rathi; Sheldon Coleman; Blythe Durbin-Johnson; Mauro Giordani; Gavin Pereira; Paul E Di Cesare
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2014-12

10.  Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty.

Authors:  Jasvinder A Singh; Jeffrey Sloan
Journal:  Clin Rheumatol       Date:  2009-06-11       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.